• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Speciality Psych Sales Force.





Just hope the new reps that have never sold Trintellix don't need any help from the reps selling it now. After all, whoever they pick are the elite of the pack! So they think...we'll see.

Well the Elite team always swoops in to save your asses - wait Apex cant get any sales for Nesina lets give it to the Elite sales team, wait the Apex reps cant move Amitiza lets give it to the Elite team! Oh yeah and you have what ---2 products while Elite has everything!

Are you scared you will be shown up by your Elite counterparts??!!! You should be scared!!!
 








Well the Elite team always swoops in to save your asses - wait Apex cant get any sales for Nesina lets give it to the Elite sales team, wait the Apex reps cant move Amitiza lets give it to the Elite team! Oh yeah and you have what ---2 products while Elite has everything!

Are you scared you will be shown up by your Elite counterparts??!!! You should be scared!!!
 




Well the Elite team always swoops in to save your asses - wait Apex cant get any sales for Nesina lets give it to the Elite sales team, wait the Apex reps cant move Amitiza lets give it to the Elite team! Oh yeah and you have what ---2 products while Elite has everything!

Are you scared you will be shown up by your Elite counterparts??!!! You should be scared!!!


Elite, saving? Get this straight - Apex never had Nesina, in fact Elite f'ed up so badly the product had to be taken generic; a first for any "major" product. The reason Apex was given Amitiza was twofold; first, to maintain the required PDE's to fulfill our obligation to Sucampo and second, to provide the Elite reps with some initial exposure to the GI market because that's where one of our two cores of business are. Elite loves to say that they have SOOO MANY products but we consider just 3 - gout, Nesina family, and now Amitiza .

After the NSS positions have been filled, expect a minor realignment of districts and regions. Also, bag mixes will change so that basically all Gen Med reps will have Trintellix and Amitiza will the only differentiation is one will have Dexilant and one will have Uloric. In actuality, you will all be Apex.

Yes, I used to be Apex but now don't have a dog in the fight. But we do have a laugh at most of the Elite reps, it seems they suffer a Napoleon complex.It's not the reps' abilities per se, both sides have some excellent people, it is that the products and where they fit in Takeda's long term plan have made the Elite reps so very defensive.
 








You must not have launched Trin (Brin) because before the Trin launch all your lazy ass Apex partners had the Nesina launch and they didnt do well. The product was switched 6 months post launch so they (now called Apex) could have another chance at a drug launch. Well you thought you were kicking ass until generics were added in (like all the other products have generics in their goal) and now you suck wind! Yeah whatever - keep trying to convince yourself that you can sell something!
 












You must not have launched Trin (Brin) because before the Trin launch all your lazy ass Apex partners had the Nesina launch and they didnt do well. The product was switched 6 months post launch so they (now called Apex) could have another chance at a drug launch. Well you thought you were kicking ass until generics were added in (like all the other products have generics in their goal) and now you suck wind! Yeah whatever - keep trying to convince yourself that you can sell something!


I'm sorry that you're so misinformed, most current Apex reps also had the unfortunate experience of trying to sell Edarbi, what a dog. Even so, we did so well that Takeda was able to sell the drug to another company, at a profit no less They then proceeded to run it completely into the ground.

And as for sucking wind with generics, Trintellix will surpass both of the remaining branded agents. All we need to do, as a company, is grow by 1/10 of 1% and that would add tens of millions to our bottom line.

I don't know why you're so hostile, but it does going to prove my earlier point about your "little man complex."